Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 226โ€“240 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3914
CLCNKA Gene Sequencing for Bartter Syndrome Type 4B (Genetic Test)

This test identifies pathogenic variants in the CLCNKA gene associated with Bartter syndrome type 4B.

Whole Blood (EDTA) or Extracted DNA or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CLCNKA gene sequence", "Pathogenic variants"]
Parameters
[]
Preparation
["Avoid blood transfusion for 90 days prior", "Bring detailed clinical history", "Arrange for genetic counsellor consultation"]
Indications
["Clinical suspicion of Bartter syndrome", "Family history of Bartter syndrome", "Unexplained electrolyte imbalances"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94257-2 ICD-10: E26.81, Z84.81, Z14.8
Clinical summary
This test identifies pathogenic variants in the CLCNKA gene associated with Bartter syndrome type 4B.
TEST-6092
CLN8 Gene Neuronal Ceroid Lipofuscinosis Type 8 (NCL8) Genetic Test

This genetic test evaluates the CLN8 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis type 8 (NCL8).

Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot 21โ€“28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CLN8 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session", "Review of relevant neurology reports, MRI findings, and prior genetic test results"]
Indications
["Suspected diagnosis of NCL8", "Carrier screening", "Family planning", "Genetic confirmation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94233-3 ICD-10: E75.4
Clinical summary
This genetic test evaluates the CLN8 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis type 8 (NCL8).
TEST-665
Clomipramine (Anafranil) Therapeutic Drug Monitoring Test

This diagnostic test evaluates the concentration of clomipramine in the patient's serum. It aids in assessing medication efficacy and potential toxicity.

Serum 2-3 weeks (monthly batch; cut-off 7th of month) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Clomipramine Concentration"]
Parameters
[{"name": "Clomipramine", "reference_range": null}]
Preparation
["Collect a 4 mL serum sample in a plain red-top tube", "Sample collection at least 12 hours after the last oral dose", "Arrange refrigerated transport with home phlebotomy team"]
Indications
["Optimizing clomipramine dosage", "Assessing therapeutic drug levels", "Monitoring for toxicity", "Evaluating patient adherence"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3530-0 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of clomipramine in the patient's serum. It aids in assessing medication efficacy and potential toxicity.
TEST-669
Clonazepam Test

This test measures the concentration of clonazepam in the serum to monitor therapeutic levels and guide dosage adjustments.

Serum 2-3 weeks (sample cut-off: 7th of each month) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Clonazepam Concentration"]
Parameters
[{"name": "Clonazepam", "reference_range": null}]
Preparation
["Collect blood before the next dose (trough level)", "Use a plain red-top tube without gel", "Ship refrigerated (2-8ยฐC)", "No special fasting required", "Avoid SST gel-barrier tubes", "Sign the mandatory Send-Out Consent Form (Form 35)"]
Indications
["Therapeutic drug monitoring for anxiety, panic, and epilepsy", "Dose adjustment", "Assessment of adherence", "Investigation of suspected toxicity or side effects"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 4011-2 ICD-10: Z79.899
Clinical summary
This test measures the concentration of clonazepam in the serum to monitor therapeutic levels and guide dosage adjustments.
TEST-673
Clorazepate Test

This diagnostic test quantifies the concentration of clorazepate and its active metabolite nordazepam in serum.

Serum 2โ€“3 weeks 2,200.00 AED
View
View test specifications and preparation
What it measures
["Clorazepate", "Nordazepam"]
Parameters
[{"name": "Clorazepate", "reference_range": null}, {"name": "Nordazepam", "reference_range": null}]
Preparation
["Schedule blood draw immediately before next scheduled dose (trough level)", "Fast for at least 6 hours prior", "Avoid alcohol for 24 hours", "Inform phlebotomist of all medications, supplements, and grapefruit consumption"]
Indications
["Monitoring therapeutic levels in patients on clorazepate", "Guiding dose adjustments", "Preventing toxicity", "Assessing adherence"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 39437-5 ICD-10: Z51.81
Clinical summary
This diagnostic test quantifies the concentration of clorazepate and its active metabolite nordazepam in serum.
TEST-676
Clozapine Therapeutic Drug Monitoring Test

This test quantitatively measures serum concentrations of clozapine and its active metabolite norclozapine.

Serum 2โ€“3 weeks (sample must arrive by the 7th of the month) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Clozapine", "Serum Norclozapine"]
Parameters
[{"name": "Clozapine", "reference_range": "350โ€“600 ng/mL"}, {"name": "Norclozapine", "reference_range": null}]
Preparation
["Blood must be drawn as a trough sample, precisely 0.5 to 1 hour before the next scheduled oral dose at steady state.", "Requires 2 mL of serum collected in a plain Red Top tube (no SST gel barrier tubes)."]
Indications
["Therapeutic dose optimization for treatment-resistant schizophrenia", "Toxicity prevention", "Monitoring patients with variable metabolism", "Assessing adherence"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3585-4 ICD-10: Z51.81
Clinical summary
This test quantitatively measures serum concentrations of clozapine and its active metabolite norclozapine.
TEST-6168
CNNM2 Gene Hypomagnesemia Type 6 Genetic Test

This test detects pathogenic variants in the CNNM2 gene associated with Hypomagnesemia Type 6, a rare autosomal dominant disorder affecting magnesium metabolism.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CNNM2 gene", "Zygosity of variants"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments required", "Pre-test genetic counselling is mandatory"]
Indications
["Individuals and families with a history of magnesium metabolism disorders", "Diagnosis of Hypomagnesemia Type 6"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82319-8 ICD-10: E83.42
Clinical summary
This test detects pathogenic variants in the CNNM2 gene associated with Hypomagnesemia Type 6, a rare autosomal dominant disorder affecting magnesium metabolism.
TEST-4090
CNTN1 Gene Genetic Test (Compton-North Congenital Myopathy)

This test identifies pathogenic variants in the CNTN1 gene, confirming the genetic basis for Compton-North congenital myopathy.

Peripheral whole blood (3โ€“5 mL in EDTA tube) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CNTN1 gene coding region variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["Inform team of recent blood transfusion or stem cell transplant", "Reschedule if febrile >38.5ยฐC"]
Indications
["Suspected Compton-North congenital myopathy", "Family history of congenital myopathy", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 56267-3 ICD-10: G71.2
Clinical summary
This test identifies pathogenic variants in the CNTN1 gene, confirming the genetic basis for Compton-North congenital myopathy.
TEST-4150
CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test

This test identifies pathogenic variants within the CNTNAP2 gene associated with cortical dysplasia-focal epilepsy syndrome.

Peripheral blood (3โ€“5 mL EDTA), FTA card spot, or extracted DNA (โ‰ฅ1 ยตg) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CNTNAP2 gene", "Deep intronic variants", "Copy-number variants"]
Parameters
[]
Preparation
["Pre-test genetic counselling session mandatory", "Detailed pedigree documentation required"]
Indications
["Diagnosis of cortical dysplasia-focal epilepsy syndrome", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78025-5 ICD-10: Q04.3, G40.0
Clinical summary
This test identifies pathogenic variants within the CNTNAP2 gene associated with cortical dysplasia-focal epilepsy syndrome.
TEST-687
Cobalt 24-Hour Urine Test

This diagnostic test evaluates recent cobalt exposure and the body's ability to excrete it.

24-Hour Urine Next day (sample received by 6:00 PM) 650.00 AED
View
View test specifications and preparation
What it measures
["Cobalt concentration in urine", "Body's excretion capacity"]
Parameters
[{"name": "Cobalt", "reference_range": null}]
Preparation
["Stop mineral supplements, Vitamin B12, and Vitamin B Complex 3 days prior.", "Avoid Gadolinium or Iodine contrast media 96 hours prior.", "Use only the metal-free container kit provided.", "Wear powder-less gloves during collection.", "Record total 24-hour urine volume."]
Indications
["Suspected industrial cobalt toxicity", "Monitoring occupational exposure", "Guiding detoxification protocols"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 14949-2 ICD-10: Z77.021
Clinical summary
This diagnostic test evaluates recent cobalt exposure and the body's ability to excrete it.
TEST-689
Cobalt Blood Test

This diagnostic test evaluates the concentration of cobalt in whole blood.

Whole Blood Next-day report (sample by 6 pm) 650.00 AED
View
View test specifications and preparation
What it measures
["Cobalt concentration", "Heavy metal levels"]
Parameters
[{"name": "Cobalt", "reference_range": null}]
Preparation
["Withhold mineral supplements, vitamin B12, and B-complex for 3 days prior (if clinically safe)", "Wait 96 hours after Gadolinium or Iodine contrast imaging"]
Indications
["Suspected occupational exposure", "Prosthetic joint wear monitoring", "Investigation of systemic toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 5681-7 ICD-10: T56.0
Clinical summary
This diagnostic test evaluates the concentration of cobalt in whole blood.
TEST-684
Cobalt, Random Urine Test

This test measures the concentration of cobalt in a random urine sample to assess recent exposure to the metal.

Random urine (mid-stream, 10 mL) Next-day report (sample received by 6 PM) 650.00 AED
View
View test specifications and preparation
What it measures
["Cobalt concentration in urine"]
Parameters
[{"name": "Cobalt", "reference_range": null}]
Preparation
["Stop all mineral supplements, vitamin B12, and vitamin B complex at least three days prior.", "Avoid contrast media for 96 hours before collection.", "Consult your doctor before stopping any prescribed medication."]
Indications
["Assessment of occupational or environmental cobalt exposure", "Monitoring chelation therapy", "Investigation of suspected cobalt toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 5686-2 ICD-10: Z77.018
Clinical summary
This test measures the concentration of cobalt in a random urine sample to assess recent exposure to the metal.
TEST-5669
COCH Gene Deafness, Autosomal Dominant Type 9 Genetic Test

This test identifies pathogenic variants in the COCH gene associated with autosomal dominant non-syndromic hearing loss type 9 (DFNA9). It uses Next Generation Sequencing (NGS) for...

Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COCH gene", "Exons and splice-site junctions of the COCH gene"]
Parameters
[]
Preparation
["No fasting required", "No special dietary restrictions", "Pre-genetic counselling session recommended"]
Indications
["Clinical suspicion of DFNA9", "Adults with post-lingual hearing loss", "Family history of hereditary hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test identifies pathogenic variants in the COCH gene associated with autosomal dominant non-syndromic hearing loss type 9 (DFNA9). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-4553
COG1 Gene Glycosylation Disorder Type 2g (CDG-2g) Genetic Test

This genetic test identifies pathogenic variants in the COG1 gene associated with congenital disorder of glycosylation type IIg.

Peripheral whole blood (EDTA) or Dry Blood Spot (DBS) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COG1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your physician."]
Indications
["Diagnosis of congenital disorder of glycosylation type IIg (CDG-2g)", "Evaluation of patients with suspected neurometabolic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-4 ICD-10: E77.8
Clinical summary
This genetic test identifies pathogenic variants in the COG1 gene associated with congenital disorder of glycosylation type IIg.
TEST-6272
COG5 Gene Glycosylation Disorder Type 2I Genetic Test

This test analyzes the COG5 gene for pathogenic variants associated with Congenital Disorder of Glycosylation type IIi (CDG-2I). It uses Next Generation Sequencing (NGS) for compre...

Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) 3 โ€“ 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COG5 gene", "Congenital Disorder of Glycosylation type IIi (CDG-2I)"]
Parameters
[]
Preparation
[]
Indications
["Suspected Congenital Disorder of Glycosylation type IIi (CDG-2I)", "Family history of COG5-related disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83240-0 ICD-10: E77.8
Clinical summary
This test analyzes the COG5 gene for pathogenic variants associated with Congenital Disorder of Glycosylation type IIi (CDG-2I). It uses Next Generation Sequencing (NGS) for comprehensive analysis.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area